| 000 | 01579 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513200610.0 | ||
| 264 | 0 | _c20000321 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a1219-4956 | ||
| 024 | 7 |
_a10.1053/paor.1999.0185 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDursun, B A | |
| 245 | 0 | 0 |
_aClinical importance of correlations between p53 immunoreactivity and clinicopathological parameters in lung carcinoma. _h[electronic resource] |
| 260 |
_bPathology oncology research : POR _c1999 |
||
| 300 |
_a285-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xpathology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xmortality |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xmortality |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xpathology |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 |
_aLung Neoplasms _xmortality |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
| 700 | 1 | _aMemiş, L | |
| 700 | 1 | _aDursun, A | |
| 700 | 1 | _aBayiz, H | |
| 700 | 1 | _aOzkul, M | |
| 773 | 0 |
_tPathology oncology research : POR _gvol. 5 _gno. 4 _gp. 285-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/paor.1999.0185 _zAvailable from publisher's website |
| 999 |
_c10563898 _d10563898 |
||